Papers/PMID:17875243
Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
Current medical research and opinion2007The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
melatonin — decreases sleep onset latency
PreliminaryGrade D, Preliminary. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×8“A significant and clinically relevant shortening of sleep latency to the same extent as most frequently used sleep medications was also found (-24.3 vs.-12.9 minutes; p = 0.028).”
Quoted verbatim from Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.. - Study
- RCT
- Duration
- 3 weeks
- Dose
- prolonged-release melatonin (Circadin) 2 mg once daily, 2 h before bedtime
- Population
- Adults aged 55-80 years with primary insomnia
Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.2007PMID:17875243Permalink